Stock Research for QGEN

Current Price


Latest Update: 2018-02-21 16:00:00

$ 33.9600
$ 33.9300
$ 33.9500

Featured Broker: TradeStation

Get the due diligence for another stock.


QGEN Stock Chart & Research Data

The QGEN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the QGEN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


QGEN Due diligence Resources & Stock Charts

The QGEN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View QGEN Detailed Price Forecast - CNN Money CNN View QGEN Detailed Summary - Google Finance
Yahoo View QGEN Detailed Summary - Yahoo! Finance Zacks View QGEN Stock Research & Analysis -

Stock Analysis

TradeIdeas View QGEN Trends & Analysis - Trade-Ideas Barrons View QGEN Major Holders - Barrons
NASDAQ View QGEN Call Transcripts - NASDAQ Seeking View QGEN Breaking News & Analysis - Seeking Alpha
Spotlight View QGEN Annual Report - OTC Report View QGEN OTC Short Report -
TradeKing View QGEN Fundamentals - TradeKing Charts View QGEN SEC Filings - Bar Chart
WSJ View Historical Prices for QGEN - The WSJ Morningstar View Performance/Total Return for QGEN - Morningstar
MarketWatch View the Analyst Estimates for QGEN - MarketWatch CNBC View the Earnings History for QGEN - CNBC
StockMarketWatch View the QGEN Earnings - StockMarketWatch MacroAxis View QGEN Buy or Sell Recommendations - MacroAxis
Bullish View the QGEN Bullish Patterns - American Bulls Short Pains View QGEN Short Pain Metrics -

Social Media Mentions

StockTwits View QGEN Stock Mentions - StockTwits PennyStocks View QGEN Stock Mentions - PennyStockTweets
Twitter View QGEN Stock Mentions - Twitter Invest Hub View QGEN Investment Forum News - Investor Hub
Yahoo View QGEN Stock Mentions - Yahoo! Message Board Seeking Alpha View QGEN Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for QGEN - Insider Cow View Insider Transactions for QGEN - Insider Cow
CNBC View QGEN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for QGEN - OTC Markets
Yahoo View Insider Transactions for QGEN - Yahoo! Finance NASDAQ View Institutional Holdings for QGEN - NASDAQ

Stock Charts

FinViz View QGEN Stock Insight & Charts - StockCharts View QGEN Investment Charts -
BarChart View QGEN Stock Overview & Charts - BarChart Trading View View QGEN User Generated Charts - Trading View

Latest Financial News for QGEN

BD (BDX) Launches PAXgene in Europe for Advanced DNA Testing
Posted on Wednesday February 21, 2018

Becton, Dickinson and Company's (BDX) PAXgene ccfDNA gets a commercial launch in Europe and enables improved DNA testing in comparison to standard EDTA tubes.

QIAGEN Welcomes New Decision by U.S. Centers for Disease Control to Use Modern Blood-Based TB Tests for Immigration Screening
Posted on Tuesday February 20, 2018

QIAGEN N.V. announced today that it welcomed a decision by the U.S. Centers for Disease control to require the use of modern blood-based tests for tuberculosis screening.

Free Post Earnings Research Report: QIAGEN’s Net Sales Rose 8%; Adjusted EPS Advanced 10%
Posted on Friday February 16, 2018

Stock Monitor: National Research Post Earnings Reporting LONDON, UK / ACCESSWIRE / February 16, 2018 / has just released a free earnings report on QIAGEN N.V. (NYSE: QGEN ). If you ...

QIAGEN's QFT-Plus Approval in Japan to Expand Customer Base
Posted on Monday February 12, 2018

QIAGEN (QGEN) continues to strengthen Molecular Diagnostics business with focus on expanding QuantiFERON-TB Gold Plus customer base.

QIAGEN Welcomes New Decision by US Centers for Disease Control to Use Modern ...
Business Wire (press release) - Feb 20, 2018
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it welcomed a decision by the U.S.

Brokers Opinions on: Qiagen NV (QGEN)
FactsReporter - 18 hours ago
Qiagen NV on 12/30/2017 reported its EPS as $0.22 with the analysts projecting the EPS of the stock as $0.21. The company beat the analyst EPS Estimate with the difference of $0.01.
First Trust Advisors LP Has $36.68 Million Stake in Qiagen NV (QGEN) - StockNewsTimes
Equities Analysts Set Expectations for Qiagen NV's Q1 2018 Earnings (NASDAQ:QGEN) - Week Herald

Lourd Capital LLC Takes Position in Qiagen NV (QGEN)
Dispatch Tribunal - 4 hours ago
Qiagen logo Lourd Capital LLC purchased a new stake in Qiagen NV (NASDAQ:QGEN) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission.
Qiagen NV (QGEN) Receives Average Rating of “Hold” from Analysts - Week Herald
Uncover the Technical data on QIAGEN NV (QGEN) - Wall Street Morning

QIAGEN Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next ...
PR Newswire (press release) - Jan 31, 2018
QIAGEN believes this proprietary system has the capabilities to help drive greater dissemination of molecular testing. Based on the proprietary DiagCORE® technology, the system was unveiled in April 2017 at the European Congress of Clinical ...
QIAGEN NV (NYSE:QGEN): Are Forecast Margins sustainable? - Simply Wall St
QIAGEN Sets 2018 Outlook For Further Growth In Adj. Sales, Adj. EPS - Markets Insider

Enter a stock symbol to view the stock details.